Photo: Getty Images
The human papillomavirus (HPV), a common sexually transmitted virus, which accounts for 70 percent of all cervical cancers, may also be linked to lung cancer, researchers found.
People with lung cancer are significantly more likely to have several forms of high-risk human papillomaviruses (HPV) antibodies compared to those without lung cancer according to researchers with the International Agency for Research on Cancer (IARC)
While a number of previous studies have demonstrated the presence of HPV in lung cancer, researchers are still unsure what, if any, role the viruses play in the development of lung cancer.
"We know that HPV can reach the lung as in respiratory papillomatosis, but whether HPV can cause frank malignancies is a question we hope to answer," said Devasena Anantharaman, Ph.D., postdoctoral fellow in the Genetic Epidemiology Group at the IARC in Lyon, France. She reported the study's findings at the AACR 102nd Annual Meeting 2011 in Orlando, Fla.
HPVs are a group of more than 150 related viruses can cause common warts, which are benign (non-cancerous) tumors. More than 40 types of HPV are more sinister. These can be sexually transmitted, causing genital warts and certain types of cancers, according to the National Cancer Institute (NCI), part of the National Institutes of Health.
In the general population HPV is quite common, particularly among young adults 20 to 25 years of age," said Anantharaman.
High-risk HPVs are the primary cause of cervical cancer, throat cancer, anal cancer, as well as in other areas of the reproductive system in men and women — vulva, vagina and penis. About 15 high-risk HPV types have been identified, including types 16 and 18, which together cause about 70 percent of cervical cancers.
It is important to note, that the great majority of infections with high-risk HPV types go away on their own and do not cause cancer, according to the NCI.
For the study, the researchers looked for several high-risk and low-risk types of HPV in 1,633 lung cancer patients and 2,729 patients without lung cancer.